There is no test for CBD, DISA’s tests will screen for THC or cannabinoids. Any test that screens for THC or cannabinoids is going to report findings for THC or cannabinoids that exceed the panel thresholds (levels). The origin of the substance will not be considered by the Medical Review Officer (MRO). DISA’s non-DOT corporate policy offers clients the option to customize testing panels.
YES - All drug testing policies have a testing “panel.” Testing panels consist of substances and level thresholds (limit of detection). DISA offers policies with customized panels, in addition to policies that require standard/regulated panels. (Please note, all DOT and some safety-sensitive, non-DOT drug testing programs have mandatory testing panels)
The employer’s responsibility is to explain that there is no exception (under DOT regulations) for the use of any product that presents as THC metabolites and exceeds set thresholds on a DOT drug screen. If it is non-DOT, they should refer to the company policy. If the policy accepts CBD oil, then that should be communicated.
Cut-off levels have been established to rule out passive or second hand smoke inhalation. Clinical studies have been conducted to establish the cut-offs, and the studies concluded that it is extremely unlikely for an individual to test positive due to passive or second hand smoke inhalation.
Our lab partners use the most advanced screening technology, including screening methods to detect synthetic urine, to ensure quality control measures are in place for donors who try and cheat on a drug test. For more information on fake urine products and their effects on drug tests, read our fake urine blog here: https://disa.com/blog/fake-urine-and-drug-test-abuse
Our preferred vendor partner, Orasure, utilizes the Intercept oral fluid collection device, which expires 24 months from the date of manufacture. So typically, they may have an 18-20-month date when received.